State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Front Immunol. 2022 Nov 30;13:1077768. doi: 10.3389/fimmu.2022.1077768. eCollection 2022.
Multiple myeloma (MM) is still an incurable plasma cell malignancy. The efficacy of immunotherapy on MM remains unsatisfactory, and the underlying molecular mechanisms still are not fully understood.
In this study, we delineated the dynamic features of immune cell in MM bone marrow (BM) along with elevated tumor cell infiltration by single-cell RNA sequencing (scRNA-seq), and investigated the underlying mechanisms on dysfunction of immune cells associated with myelomagenesis.
We found that immune cells were activated in those patients with low infiltration of tumor cells, meanwhile suppressed with elevated infiltration of MM cells, which facilitated MM escaping from immune surveillance. Besides PD-1, abnormal expression of kinases, and were involved in the defect of immune cells in MM patients. Importantly, we found aberrant metabolic processes were associated with the immunosuppressive microenvironment in MM patients. Disordered amino acid metabolism promoted the dysfunction of cytotoxicity CD8 T cells as well as lipid metabolism disorder was associated with the dysregulation of NK and DCs in MM. As metabolic checkpoints, kinases would be potential effective strategies for MM immunotherapy.
In summary, redressing the disordered metabolism should be the key points to get promising effects in immune-based therapies.
多发性骨髓瘤(MM)仍然是一种无法治愈的浆细胞恶性肿瘤。免疫疗法对 MM 的疗效仍不尽如人意,其潜在的分子机制仍不完全清楚。
在这项研究中,我们通过单细胞 RNA 测序(scRNA-seq)描绘了 MM 骨髓(BM)中免疫细胞的动态特征以及肿瘤细胞浸润程度的升高,并研究了与骨髓瘤发生相关的免疫细胞功能障碍的潜在机制。
我们发现,在肿瘤细胞浸润程度较低的患者中,免疫细胞被激活,而在 MM 细胞浸润程度较高的患者中,免疫细胞受到抑制,这有助于 MM 逃避免疫监视。除了 PD-1,异常表达的激酶和在 MM 患者的免疫细胞缺陷中也有涉及。重要的是,我们发现异常的代谢过程与 MM 患者的免疫抑制微环境有关。紊乱的氨基酸代谢促进了细胞毒性 CD8 T 细胞的功能障碍,而脂质代谢紊乱与 MM 中 NK 和 DC 的失调有关。作为代谢检查点,激酶可能是 MM 免疫治疗的潜在有效策略。
总之,纠正代谢紊乱应该是在免疫治疗中取得良好效果的关键。